<p>Maximus, Inc.（紐約證券交易所代碼：MMS - 獲取免費報告）首席財務官 David Mutryn 於 2 月 9 日星期一購買了 1,000 股該股票。該股票的平均購買成本為每股 75.62 美元，總交易額為 75,620.00 美元。收購完成後，首席財務官在公司中持有 40,037 股，價值為 3,027,597.94 美元。這代表其持股增加了 2.56%。此次購買在向美國證券交易委員會（SEC）提交的文件中披露，相關信息可通過 SEC 網站訪問。</p>
<h2>Maximus 價格表現</h2>
<p>在週一的午盤交易中，MMS 的股價上漲了 0.01 美元，達到了 75.09 美元。該公司交易了 1,168,871 股，而其平均交易量為 674,064 股。該股票的市值為 41 億美元，市盈率為 11.43，貝塔值為 0.56。該公司 50 日移動平均線為 90.07 美元，200 日移動平均線為 86.58 美元。公司的債務與股本比率為 0.88，速動比率為 2.34，流動比率為 2.34。Maximus, Inc.的 52 周低點為 63.77 美元，52 周高點為 100.00 美元。</p>
<p>Maximus（紐約證券交易所代碼：MMS - 獲取免費報告）最近一次發佈財報是在 2 月 5 日星期四。這家健康服務提供商報告本季度每股收益為 1.85 美元，超出分析師一致預期的 1.84 美元，超出幅度為 0.01 美元。Maximus 的淨利潤率為 6.92%，股本回報率為 25.30%。該公司本季度的收入為 13.5 億美元，而分析師預期為 13.7 億美元。去年同期，該公司每股收益為 1.61 美元。與去年同期相比，Maximus 本季度的收入下降了 4.1%。Maximus 已將其 2026 財年的指引設定為每股收益 8.050-8.350 美元。分析師平均預測 Maximus, Inc.在當前財年將發佈每股收益 6.15 美元。</p>
<h2>Maximus 增加股息</h2>
<p>該公司最近還披露了一項季度股息，將於 3 月 2 日星期一支付。2 月 13 日星期五的股東將獲得 0.33 美元的股息。這比 Maximus 之前的季度股息 0.30 美元有所增加。該股息的除息日期為 2 月 13 日星期五。這代表每年 1.32 美元的股息，收益率為 1.8%。Maximus 的股息支付比率目前為 18.26%。</p>
<h2>分析師評級變動</h2>
<p>MMS 成為多份研究報告的主題。Zacks Research 在 12 月 30 日星期二的研究報告中將 Maximus 的評級從 “持有” 上調至 “強力買入”。Wall Street Zen 在週六的報告中將 Maximus 的評級從 “買入” 下調至 “持有”。最後，Weiss Ratings 在 12 月 29 日星期一的研究報告中重申了對 Maximus 的 “買入（b-）” 評級。一位股票研究分析師對該股票給予了 “強力買入” 評級，另一位則給予了 “買入” 評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “強力買入”。</p>
<p><strong>閲讀我們對 Maximus 的最新分析</strong></p>
<h2>機構資金流入和流出</h2>
<p>對該股票的對沖基金最近進行了買賣。Dimensional Fund Advisors LP 在第三季度將其在 Maximus 的持股增加了 2.0%。Dimensional Fund Advisors LP 目前擁有 1,869,573 股該健康服務提供商的股票，價值為 170,812,000 美元，此前在該期間又購買了 36,989 股。Geode Capital Management LLC 在第四季度將其在 Maximus 的持股增加了 0.3%。Geode Capital Management LLC 目前擁有 1,482,079 股該健康服務提供商的股票，價值為 127,952,000 美元，此前在該期間又購買了 5,130 股。Boston Partners 在第三季度將其在 Maximus 的持股增加了 47.0%。Boston Partners 目前擁有 966,139 股該健康服務提供商的股票，價值為 88,236,000 美元，此前在上個季度又購買了 308,892 股。Reinhart Partners LLC 在第三季度將其在 Maximus 的持股增加了 0.8%。Reinhart Partners LLC 目前擁有 921,578 股該健康服務提供商的股票，價值為 84,206,000 美元，此前在該期間又收購了 7,722 股。最後，Stephens Investment Management Group LLC 在第三季度將其在 Maximus 的持股增加了 49.0%。Stephens Investment Management Group LLC 目前擁有 720,943 股該健康服務提供商的股票，價值為 65,873,000 美元，此前在上個季度又收購了 237,097 股。機構投資者和對沖基金持有該公司 97.21% 的股票。</p>
<h2>Maximus 公司簡介</h2>
<p>（獲取免費報告）</p>
<p>Maximus, Inc.（紐約證券交易所代碼：MMS）是一家全球政府服務提供商，專注於提供健康和人類服務項目。該公司與聯邦、州和地方機構合作，管理和實施支持個人和家庭在不同生活階段的項目。主要服務領域包括醫療補助、醫療保險、兒童健康保險計劃（CHIP）及其他公共援助項目的資格認定和入學服務，以及呼叫中心運營、案件管理和項目完整性解決方案。</p>
<h2>瞭解更多</h2>
<ul>
<li>我們更看好的五隻股票比 Maximus 更好</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>你的銀行賬户不再安全</li>
<li>在 2026 年 5 月之前購買這隻黃金股票</li>
<li>黃金市場崩潰的那一天</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw"/></p>
<p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元在 Maximus 嗎？</h2>
<p>在考慮 Maximus 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議他們在更廣泛的市場注意到之前立即購買……而 Maximus 並不在名單上。</p>
<p>儘管 Maximus 目前在分析師中獲得了強烈買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

<p>Maximus 首席財務官 David Mutryn 以每股 75.62 美元的價格購買了 1,000 股公司股票，總計 75,620 美元。這次購買使他的持股比例增加了 2.56%，使他的總股份達到 40,037 股，估值約為 303 萬美元。該股票最近的交易價格為 75.09 美元，市值為 41 億美元。Maximus 報告每股收益為 1.85 美元，超出預期，並宣佈每股股息增加至 0.33 美元，將於 3 月 2 日支付。分析師對該股票的評級不一，平均評級為 “強烈買入”</p>

<p>Maximus, Inc. (NYSE:MMS - Get Free Report) CFO David Mutryn purchased 1,000 shares of the stock in a transaction that occurred on Monday, February 9th. The stock was acquired at an average cost of $75.62 per share, for a total transaction of $75,620.00. Following the completion of the acquisition, the chief financial officer owned 40,037 shares in the company, valued at $3,027,597.94. This represents a 2.56% increase in their position. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website.</p>
<div class="lb-trans"><p>Maximus, Inc.（紐約證券交易所代碼：MMS - 獲取免費報告）首席財務官 David Mutryn 於 2 月 9 日星期一購買了 1,000 股該股票。該股票的平均購買成本為每股 75.62 美元，總交易額為 75,620.00 美元。收購完成後，首席財務官在公司中持有 40,037 股，價值為 3,027,597.94 美元。這代表其持股增加了 2.56%。此次購買在向美國證券交易委員會（SEC）提交的文件中披露，相關信息可通過 SEC 網站訪問。</p>
</div><h2>Maximus Price Performance</h2>
<div class="lb-trans"><h2>Maximus 價格表現</h2>
</div><p>Shares of MMS traded up $0.01 during midday trading on Monday, hitting $75.09. 1,168,871 shares of the company traded hands, compared to its average volume of 674,064. The stock has a market cap of $4.10 billion, a price-to-earnings ratio of 11.43 and a beta of 0.56. The firm has a 50 day moving average of $90.07 and a 200-day moving average of $86.58. The company has a debt-to-equity ratio of 0.88, a quick ratio of 2.34 and a current ratio of 2.34. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $100.00.</p>
<div class="lb-trans"><p>在週一的午盤交易中，MMS 的股價上漲了 0.01 美元，達到了 75.09 美元。該公司交易了 1,168,871 股，而其平均交易量為 674,064 股。該股票的市值為 41 億美元，市盈率為 11.43，貝塔值為 0.56。該公司 50 日移動平均線為 90.07 美元，200 日移動平均線為 86.58 美元。公司的債務與股本比率為 0.88，速動比率為 2.34，流動比率為 2.34。Maximus, Inc.的 52 周低點為 63.77 美元，52 周高點為 100.00 美元。</p>
</div><p>Maximus (NYSE:MMS - Get Free Report) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating analysts' consensus estimates of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.37 billion. During the same period last year, the firm posted $1.61 earnings per share. Maximus's revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. On average, analysts forecast that Maximus, Inc. will post 6.15 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>Maximus（紐約證券交易所代碼：MMS - 獲取免費報告）最近一次發佈財報是在 2 月 5 日星期四。這家健康服務提供商報告本季度每股收益為 1.85 美元，超出分析師一致預期的 1.84 美元，超出幅度為 0.01 美元。Maximus 的淨利潤率為 6.92%，股本回報率為 25.30%。該公司本季度的收入為 13.5 億美元，而分析師預期為 13.7 億美元。去年同期，該公司每股收益為 1.61 美元。與去年同期相比，Maximus 本季度的收入下降了 4.1%。Maximus 已將其 2026 財年的指引設定為每股收益 8.050-8.350 美元。分析師平均預測 Maximus, Inc.在當前財年將發佈每股收益 6.15 美元。</p>
</div><h2>Maximus Increases Dividend</h2>
<div class="lb-trans"><h2>Maximus 增加股息</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 2nd. Shareholders of record on Friday, February 13th will be given a $0.33 dividend. This is a boost from Maximus's previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 1.8%. Maximus's dividend payout ratio is currently 18.26%.</p>
<div class="lb-trans"><p>該公司最近還披露了一項季度股息，將於 3 月 2 日星期一支付。2 月 13 日星期五的股東將獲得 0.33 美元的股息。這比 Maximus 之前的季度股息 0.30 美元有所增加。該股息的除息日期為 2 月 13 日星期五。這代表每年 1.32 美元的股息，收益率為 1.8%。Maximus 的股息支付比率目前為 18.26%。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析師評級變動</h2>
</div><p>MMS has been the topic of a number of research reports. Zacks Research raised shares of Maximus from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Tuesday, December 30th. Wall Street Zen cut Maximus from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a report on Saturday. Finally, Weiss Ratings reaffirmed a &#34;buy (b-)&#34; rating on shares of Maximus in a research note on Monday, December 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of &#34;Strong Buy&#34;.</p>
<div class="lb-trans"><p>MMS 成為多份研究報告的主題。Zacks Research 在 12 月 30 日星期二的研究報告中將 Maximus 的評級從 “持有” 上調至 “強力買入”。Wall Street Zen 在週六的報告中將 Maximus 的評級從 “買入” 下調至 “持有”。最後，Weiss Ratings 在 12 月 29 日星期一的研究報告中重申了對 Maximus 的 “買入（b-）” 評級。一位股票研究分析師對該股票給予了 “強力買入” 評級，另一位則給予了 “買入” 評級。根據 MarketBeat.com 的數據，該股票的平均評級為 “強力買入”。</p>
</div><p><strong>Read Our Latest Analysis on Maximus</strong></p>
<div class="lb-trans"><p><strong>閲讀我們對 Maximus 的最新分析</strong></p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>機構資金流入和流出</h2>
</div><p>Hedge funds have recently bought and sold shares of the stock. Dimensional Fund Advisors LP increased its holdings in shares of Maximus by 2.0% in the third quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock valued at $170,812,000 after purchasing an additional 36,989 shares during the period. Geode Capital Management LLC increased its holdings in Maximus by 0.3% in the 4th quarter. Geode Capital Management LLC now owns 1,482,079 shares of the health services provider's stock worth $127,952,000 after buying an additional 5,130 shares during the period. Boston Partners raised its position in Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider's stock worth $88,236,000 after buying an additional 308,892 shares during the last quarter. Reinhart Partners LLC. lifted its stake in Maximus by 0.8% during the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider's stock valued at $84,206,000 after acquiring an additional 7,722 shares during the period. Finally, Stephens Investment Management Group LLC boosted its holdings in shares of Maximus by 49.0% in the 3rd quarter. Stephens Investment Management Group LLC now owns 720,943 shares of the health services provider's stock valued at $65,873,000 after acquiring an additional 237,097 shares during the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.</p>
<div class="lb-trans"><p>對該股票的對沖基金最近進行了買賣。Dimensional Fund Advisors LP 在第三季度將其在 Maximus 的持股增加了 2.0%。Dimensional Fund Advisors LP 目前擁有 1,869,573 股該健康服務提供商的股票，價值為 170,812,000 美元，此前在該期間又購買了 36,989 股。Geode Capital Management LLC 在第四季度將其在 Maximus 的持股增加了 0.3%。Geode Capital Management LLC 目前擁有 1,482,079 股該健康服務提供商的股票，價值為 127,952,000 美元，此前在該期間又購買了 5,130 股。Boston Partners 在第三季度將其在 Maximus 的持股增加了 47.0%。Boston Partners 目前擁有 966,139 股該健康服務提供商的股票，價值為 88,236,000 美元，此前在上個季度又購買了 308,892 股。Reinhart Partners LLC 在第三季度將其在 Maximus 的持股增加了 0.8%。Reinhart Partners LLC 目前擁有 921,578 股該健康服務提供商的股票，價值為 84,206,000 美元，此前在該期間又收購了 7,722 股。最後，Stephens Investment Management Group LLC 在第三季度將其在 Maximus 的持股增加了 49.0%。Stephens Investment Management Group LLC 目前擁有 720,943 股該健康服務提供商的股票，價值為 65,873,000 美元，此前在上個季度又收購了 237,097 股。機構投資者和對沖基金持有該公司 97.21% 的股票。</p>
</div><h2>Maximus Company Profile</h2>
<div class="lb-trans"><h2>Maximus 公司簡介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Maximus, Inc NYSE: MMS is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children's Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.</p>
<div class="lb-trans"><p>Maximus, Inc.（紐約證券交易所代碼：MMS）是一家全球政府服務提供商，專注於提供健康和人類服務項目。該公司與聯邦、州和地方機構合作，管理和實施支持個人和家庭在不同生活階段的項目。主要服務領域包括醫療補助、醫療保險、兒童健康保險計劃（CHIP）及其他公共援助項目的資格認定和入學服務，以及呼叫中心運營、案件管理和項目完整性解決方案。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>瞭解更多</h2>
</div><ul>
<li>Five stocks we like better than Maximus</li>
<li>NEW LAW: Congress Approves Setup For Digital Dollar?</li>
<li>Your Bank Account Is No Longer Safe</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>The day the gold market broke</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票比 Maximus 更好</li>
<li>新法律：國會批准數字美元的設立？</li>
<li>你的銀行賬户不再安全</li>
<li>在 2026 年 5 月之前購買這隻黃金股票</li>
<li>黃金市場崩潰的那一天</li>
<li>一位前 CIA 特工對即將到來的崩潰的看法</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw" alt="" original-src="https://www.marketbeat.com/scripts/InsiderTradesChart.ashx?Prefix=NYSE&amp;Symbol=MMS"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或評論發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Maximus Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元在 Maximus 嗎？</h2>
</div><p>Before you consider Maximus, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Maximus 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其向客户推薦的股票。MarketBeat 已經識別出五隻頂級分析師正在悄悄向客户推薦的股票，建議他們在更廣泛的市場注意到之前立即購買……而 Maximus 並不在名單上。</p>
</div><p>While Maximus currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>儘管 Maximus 目前在分析師中獲得了強烈買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Maximus (NYSE:MMS) 的首席財務官購入了價值 75,620.00 美元的股票